Lupus and the medicines used to treat it can affect your child at school. Be your child’s advocate by helping people at school understand what your child needs to succeed. Learning about how lupus may ...

Since lupus can cause problems anywhere in the body, your child may need to see different types of pediatricians (doctors who provide care to children from birth to young adulthood) and health care ...

In the last few years, thanks to the pandemic, we have all become very aware of the importance of our immune systems. But sometimes, the system that is supposed to protect us from disease, ends up ...

SAN DIEGO — Children born to women with lupus are at twice the risk for autism spectrum disorders as children born to women without a chronic inflammatory disease, according to a new study. "Mothers ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a 200 mg Benlysta autoinjector for children aged 5 years and ...

Please provide your email address to receive an email when new articles are posted on . Outcome disparities between Black and white patients were worse in children’s hospitals that served more Black ...

With this approval, pediatric patients aged five years and older with active lupus nephritis will have a first-of-its-kind treatment option for at-home administration. PHILADELPHIA--(BUSINESS WIRE)-- ...

The U.S. Food and Drug Administration has given Seattle Children’s the green light to conduct a clinical trial for a drug that researchers hope can help fight pediatric lupus. The drug known as ...

WASHINGTON, June 26, 2025 /PRNewswire/ -- This year, the Lupus Foundation of America (LFA) is pleased to announce two recipients of grants supporting pediatric lupus research. This year's recipients ...

Systemic lupus erythematosus (SLE) is an autoimmune disease that can be seen in children as well as adults. In children, it is called childhood-onset lupus, pediatric SLE, or juvenile lupus. SLE ...

Seattle Children’s is the first FDA-authorized site to deliver an experimental CAR T-cell therapy to children with lupus, the system said March 11. About 20% of lupus patients have disease onset ...